Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Universität des Saarlandes
National Institutes of Health Clinical Center (CC)
University of Nebraska
National Cancer Institute (NCI)
Children's Oncology Group
University of Nebraska
University of Nebraska
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
Goethe University
Gustave Roussy, Cancer Campus, Grand Paris
SWOG Cancer Research Network
Seagen Inc.
Roswell Park Cancer Institute
Universität des Saarlandes
Universität des Saarlandes
Roswell Park Cancer Institute
German High-Grade Non-Hodgkin's Lymphoma Study Group
Masonic Cancer Center, University of Minnesota
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
Seagen Inc.
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Samsung Medical Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Northside Hospital, Inc.
European Organisation for Research and Treatment of Cancer - EORTC
Swiss Cancer Institute
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center